Relationship Between Bispectral Index, EEG Features, and Propofol Effect-site Concentration in Young and Elderly Patients.

March 15, 2022 updated by: Pontificia Universidad Catolica de Chile
The aim of this study is to describe the BIS values and electroencephalographic patterns during total intravenous anesthesia with propofol-remifentanyl, in patients from 18 to 85 years.

Study Overview

Status

Completed

Intervention / Treatment

Detailed Description

Propofol is an anesthetic drug regularly used in elderly patients requiring anesthesia. The electroencephalographic pattern recognized when propofol is administered is different from the pattern obtained in younger patients. Both groups present alpha and slow delta bands, but younger patients present more intense electroencephalographic bands than older patients (1). The correlation between BIS values and the power of electroencephalographic frequency bands during propofol-remifentanyl anesthesia has not been determined.

The investigators will describe the changes in BIS values and electroencephalographic patterns in young and elderly patients receiving propofol-remifentanyl anesthesia for elective surgery, at different propofol concentration levels. Formal characterization of the dynamic relationship between propofol concentrations at the effect site (Ce), spectral power, and BIS values may provide clinically relevant information to design propofol dose schemes in elderly patients.

The investigators will carry out a prospective observational clinical study at the Clinical Hospital of the Catholic University of Chile. 30 patients, aged 18-85 years, scheduled to undergo elective surgery will be recruited. Standard monitoring and 2 frontal EEG monitors will be installed: Sedline® and BIS®. The electroencephalographic signal from these monitors will be recorded simultaneously from anesthesia induction until extubation. Propofol will be started at a rate of 15-20 mg/kg/hr in patients >65 years and 20-25 mg/kg/hr in younger patients (<65 years) until a suppression rate (SR) >1% appears in the BIS® EEG monitor. If the SR is not achieved, the infusion rate can be increased by 5 mg/kg/hr every 5 minutes until 25 mg/kg/hr in the elderly group and 30 mg/kg/hr in the younger group. When the SR appears, propofol infusion will be stopped. The induction phase will be considered completed at this point. Loss of response (LOR), defined as the timepoint when patients became unresponsive to verbal commands, soft shaking, and eyelash reflex, will be assessed every 30 seconds. When patients become apneic, positive pressure mask ventilation will be started gently at a rate of 10 breaths per minute. After induction of anesthesia, opioids and neuromuscular blocking drugs will be given to facilitate tracheal intubation. When BIS values increase to recommended hypnotic levels for surgery (40-60), the propofol infusion rate will be started again at half of the induction rate. This rate will be adjusted to maintain the alpha band present in the Sedline spectrogram and SEF95 between 8-12 Hz. BIS monitor will be covered and hidden from the attending anesthesiologist during the maintenance phase. After surgery ends, EEG monitoring will continue until the patient's extubation. One hour after extubation, the Brice questionnaire will be performed to detect intraoperative awakening. Propofol concentration will be estimated using the Schnider model.

Study Type

Observational

Enrollment (Actual)

30

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

    • Metropolitana
      • Santiago, Metropolitana, Chile, 8330024
        • Division de Anestesia - Pontificia Universidad Catolica de Chile

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

18 years to 90 years (Adult, Older Adult)

Accepts Healthy Volunteers

No

Genders Eligible for Study

All

Sampling Method

Non-Probability Sample

Study Population

Elderly patients scheduled for surgery are an understudied population. Incidence of postoperative delirium and other complications can be related to changes in cerebral dynamics under anesthesia, with effects observed even after the use of anesthetics agents.

Formal characterization of the dynamic relationship between propofol concentrations at the effect site (Ce), spectral power, and BIS values may provide clinically relevant information to design propofol dose schemes in young and elderly patients.

Description

Inclusion Criteria:

  • Adult patients scheduled for elective surgery requiring general anesthesia.
  • American Society of Anesthesiology (ASA) Score I or II

Exclusion Criteria:

  • Patients with neurological diseases or history of cognitive impairment.
  • Requiring the use of two or more drugs affecting Central nervous system
  • History of drugs or alcohol abuse
  • Body mass index over 35 kg/m^2
  • Propofol allergy
  • Cardiac congestive failure
  • History of coronary syndrome

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Observational Models: Cohort
  • Time Perspectives: Cross-Sectional

Cohorts and Interventions

Group / Cohort
Intervention / Treatment
Young Patients (Patients aged 18 to 65 years.)
Propofol infusion rate will be started at 20-25 mg/kg/hr until SR achieved. Then restarted at half of the initial rate. Maintenance of anesthesia will be guided by Sedline Monitor to maintain an alpha band present in the spectrogram and SEF95 between 8-12 Hz. BIS monitor will be covered. Both EEG signals (Sedline and BIS) will be registered simultaneously until the patient's extubation.
Propofol will be started at a rate of 15-20 mg/kg/hr in patients >65 years and 20-25 mg/kg/hr in younger patients (<65 years) until a suppression rate (SR) is achieved. If not, can be increased by 5 mg/kg/hr every 5 minutes up to 25 mg/kg/hr in the elderly group and 30 mg/kg/hr in the younger group or after 15 minutes have passed. When the SR appears, propofol infusion will be stopped. Then restarted at half of the initial rate. Maintenance of anesthesia will be guided by Sedline Monitor to maintain an alpha band present in the spectrogram and SEF95 between 8-12 Hz. BIS monitor will be covered. Both EEG signals (Sedline and BIS) will be registered simultaneously until the patient's extubation.
Other Names:
  • Diprivan
  • Propoven
Elderly patients (Patients aged 65 to 85 years. )
Propofol infusion rate will be started at 15-20 mg/kg/hr until SR achieved. Then restarted at half of the initial rate. Maintenance of anesthesia will be guided by Sedline Monitor to maintain an alpha band present in the spectrogram and SEF95 between 8-12 Hz. BIS monitor will be covered. Both EEG signals (Sedline and BIS) will be registered simultaneously until the patient's extubation.
Propofol will be started at a rate of 15-20 mg/kg/hr in patients >65 years and 20-25 mg/kg/hr in younger patients (<65 years) until a suppression rate (SR) is achieved. If not, can be increased by 5 mg/kg/hr every 5 minutes up to 25 mg/kg/hr in the elderly group and 30 mg/kg/hr in the younger group or after 15 minutes have passed. When the SR appears, propofol infusion will be stopped. Then restarted at half of the initial rate. Maintenance of anesthesia will be guided by Sedline Monitor to maintain an alpha band present in the spectrogram and SEF95 between 8-12 Hz. BIS monitor will be covered. Both EEG signals (Sedline and BIS) will be registered simultaneously until the patient's extubation.
Other Names:
  • Diprivan
  • Propoven

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
BIS values at which EEG patterns appears during induction of anesthesia with propofol.
Time Frame: From induction of anesthesia until suppression rate appears, an average of 15 minutes.
BIS values correlated to specific EEG patterns (frequency bands, complexity measures and burst suppression)
From induction of anesthesia until suppression rate appears, an average of 15 minutes.

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Propofol effect-site concentration (µg/ml) required to observe specific EEG patterns
Time Frame: From induction of anesthesia until loss of consciousness, an average of 15 minutes.
Propofol effect-site concentrations achieved at the time that specific EEG patterns appear (frequency bands power, complexity measures and burst suppression).
From induction of anesthesia until loss of consciousness, an average of 15 minutes.
Propofol effect-site concentration (µg/ml) required to achieve loss of consciousness
Time Frame: From Induction of anesthesia until suppression rate appears, an average of 15 minutes.
Propofol effect-site concentration (µg/ml) at the moment of loss of consciousness
From Induction of anesthesia until suppression rate appears, an average of 15 minutes.
BIS values at loss of consciousness
Time Frame: From Induction of anesthesia until suppression rate appears, an average of 15 minutes.
BIS values at the moment of loss of consciousness
From Induction of anesthesia until suppression rate appears, an average of 15 minutes.
Percentage of time with BIS values between 40-60 and out of this range.
Time Frame: From induction of anesthesia until patient's extubation, an average of 90 minutes.
Percentage of time that BIS values are between 40-60 and out of this range.
From induction of anesthesia until patient's extubation, an average of 90 minutes.
Time to achieve loss of consciousness
Time Frame: From Induction of anesthesia until loss of consciousness, an average of 10 minutes.
Time (minutes) to achieve loss of consciousness.
From Induction of anesthesia until loss of consciousness, an average of 10 minutes.
Time to achieve loss suppression rate >1% in BIS monitor.
Time Frame: From Induction of anesthesia until suppression rate appears, an average of 15 minutes.
Time (minutes) to achieve loss suppression rate >1% in BIS monitor.
From Induction of anesthesia until suppression rate appears, an average of 15 minutes.

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Investigators

  • Principal Investigator: Daniela Muñoz, MD, Pontificia Universidad Catolica de Chile

Publications and helpful links

The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

December 11, 2020

Primary Completion (Actual)

March 30, 2021

Study Completion (Actual)

May 30, 2021

Study Registration Dates

First Submitted

January 19, 2021

First Submitted That Met QC Criteria

February 25, 2021

First Posted (Actual)

March 1, 2021

Study Record Updates

Last Update Posted (Actual)

March 16, 2022

Last Update Submitted That Met QC Criteria

March 15, 2022

Last Verified

February 1, 2021

More Information

Terms related to this study

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

No

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

Yes

Studies a U.S. FDA-regulated device product

No

product manufactured in and exported from the U.S.

Yes

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Aging

Clinical Trials on Propofol

Subscribe